Benzinga's Top Upgrades, Downgrades For October 5, 2017

Morgan Stanley upgraded Regal Entertainment Group RGC from Underweight to Equal-Weight. Regal Entertainment shares gained 1 percent to $17.09 in pre-market trading.
Stephens & Co. upgraded BB&T Corporation BBT from Equal-Weight to Overweight. BB&T shares fell 1.09 percent to close at $46.37 on Wednesday.
Morgan Stanley upgraded T. Rowe Price Group Inc TROW from Underweight to Equal-Weight. T. Rowe Price shares gained 0.54 percent to close at $91.41 on Wednesday.
Analysts at Baird upgraded AmerisourceBergen Corp. ABC from Neutral to Outperform. AmerisourceBergen shares fell 0.17 percent to close at $82.74 on Wednesday.
Canaccord Genuity upgraded Microsoft Corporation MSFT from Hold to Buy. Microsoft shares rose 0.95 percent to $75.40 in pre-market trading.
Bank of America upgraded Sherwin-Williams Co SHW from Underperform to Buy. Sherwin-Williams shares gained 0.78 percent to $377.08 in pre-market trading.
Morgan Stanley upgraded Biogen Inc BIIB from Equal-Weight to Overweight. Biogen shares rose 2.15 percent to $321.70 in pre-market trading.
Analysts at Raymond James upgraded East West Bancorp, Inc. EWBC from Underperform to Market Perform. East West Bancorp shares fell 1.89 percent to close at $58.72 on Wednesday.

Analysts at Morgan Stanley downgraded Celgene Corporation CELG from Equal-Weight to Underweight. Celgene shares fell 2.71 percent to $142.55 in pre-market trading.
Piper Jaffray downgraded Coach Inc COH from Overweight to Neutral. Coach shares dropped 1.28 percent to $39.21 in pre-market trading.
Oppenheimer downgraded CarMax, Inc KMX from Outperform to Perform. CarMax shares fell 1.18 percent to $75.55 in pre-market trading.
Canaccord Genuity downgraded Mallinckrodt PLC MNK from Buy to Hold. Mallinckrodt shares slipped 2.28 percent to $36.51 in pre-market trading.
Jefferies downgraded RPC, Inc. RES from Buy to Hold. RPC shares fell 0.54 percent to $23.95 in pre-market trading.
Stifel Nicolaus downgraded Momenta Pharmaceuticals, Inc. MNTA from Buy to Hold. Momenta Pharmaceuticals shares declined 2.35 percent to $14.74 in pre-market trading.
Deutsche Bank downgraded Western Digital Corp WDC from Buy to Hold. Western Digital shares declined 2.2 percent to $82.50 in pre-market trading.
Analysts at Citigroup downgraded GrubHub Inc GRUB from Buy to Neutral. GrubHub shares slipped 1.77 percent to $53.14 in pre-market trading.
Stephens & Co. downgraded PNC Financial Services Group Inc PNC from Overweight to Equal-Weight. PNC Financial shares rose 0.07 percent to close at $134.27 on Wednesday.
Compass Point downgraded Navient Corp NAVI from Buy to Neutral. Navient shares declined 1.74 percent to close at $14.70 on Wednesday.

Analysts at Pivotal Research initiated coverage on Nike Inc NKE with a Hold rating. The price target for Nike is set to $56. Nike shares closed at $52.08 on Wednesday.
Oppenheimer initiated coverage on Gilead Sciences, Inc. GILD with a Perform rating. Gilead Sciences shares closed at $82.42 on Wednesday.
Analysts at Mizuho initiated coverage on FibroGen Inc FGEN with a Neutral rating. The price target for FibroGen is set to $61. FibroGen shares closed at $60.10 on Wednesday.
Deutsche Bank initiated coverage on DowDuPont Inc DWDP with a Buy rating. The price target for DowDuPont is set to $80. DowDuPont shares closed at $70.45 on Wednesday.
Pivotal Research initiated coverage on VF Corp VFC with a Buy rating. The price target for VF Corp is set to $75. VF Corp shares closed at $64.91 on Wednesday.
Jefferies initiated coverage on Keane Group Inc FRAC with a Buy rating. The price target for Keane Group is set to $20. Keane Group shares closed at $17.01 on Wednesday.
Analysts at Mizuho initiated coverage of Akebia Therapeutics Inc AKBA with a Buy rating. The price target for Akebia Therapeutics is set to $24. Akebia Therapeutics shares closed at $19.23 on Wednesday.
Analysts at Pivotal Research initiated coverage on Under Armour Inc UAA with a Hold rating. The price target for Under Armour is set to $17. Under Armour shares closed at $16.47 on Wednesday.

Analyst Calendar